High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation
- PMID: 10785483
- DOI: 10.1006/gyno.2000.5788
High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation
Abstract
Objective: The goal of this study was to identify risk factors in patients with node-positive stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy with pelvic lymph node dissection and postoperative irradiation.
Methods: Two hundred forty-two patients with FIGO stage IB, IIA, and IIB cervical carcinoma underwent radical hysterectomy with pelvic lymph node dissection; pathological analysis of the surgical specimen showed positive lymph nodes in 59 patients. These 59 patients were further treated with postoperative radiotherapy. Eighteen patients were in stage IB, 4 in stage IIA, and 37 in stage IIB. Histological tumor type, tumor size, lymph-vascular space invasion, parametrium infiltration, number of positive nodes, and involvement of common iliac nodes were assessed for correlation with cancer recurrence.
Results: When all these variables were assessed in the Cox proportional regression analysis, parametrium infiltration (P = 0. 0199) and number of positive nodes (two or more nodes) (P = 0.0483) revealed the factor correlating significantly with disease-specific survival. Based on these two factors, node-positive patients could be divided into low-risk (n = 11), intermediate-risk (n = 29), and high-risk (n = 19) groups. The 5-year disease-specific survival for the low-risk group was 100% which was significantly better than the 39.1% for the high-risk group (P = 0.0012).
Conclusion: For patients in the high-risk group, it may be worthwhile to consider new strategies to improve survival.
Copyright 2000 Academic Press.
Similar articles
-
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.Gynecol Oncol. 1994 Jul;54(1):4-9. doi: 10.1006/gyno.1994.1157. Gynecol Oncol. 1994. PMID: 8020837
-
The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.Gynecol Oncol. 1999 Dec;75(3):328-33. doi: 10.1006/gyno.1999.5527. Gynecol Oncol. 1999. PMID: 10600284
-
Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.Cancer. 1997 Oct 1;80(7):1234-40. Cancer. 1997. PMID: 9317173
-
Cervical cancer: combined modality therapy.Cancer J. 2001 Jul-Aug;7 Suppl 1:S47-50. Cancer J. 2001. PMID: 11504285 Review.
-
Long-term observation of patients treated by postoperative extended-field irradiation for nodal metastases from cervical carcinoma stages IB, IIA, and IIB.Gynecol Oncol. 1995 Jul;58(1):4-10. doi: 10.1006/gyno.1995.1175. Gynecol Oncol. 1995. PMID: 7789888 Review.
Cited by
-
Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy.J Gynecol Oncol. 2009 Jun;20(2):132. doi: 10.3802/jgo.2009.20.2.132. Epub 2009 Jun 29. J Gynecol Oncol. 2009. PMID: 19590728 Free PMC article. No abstract available.
-
Role of 18F-FDG PET/CT in the carcinoma of the uterus: a review of literature.Yonsei Med J. 2014 Nov;55(6):1467-72. doi: 10.3349/ymj.2014.55.6.1467. Yonsei Med J. 2014. PMID: 25323881 Free PMC article. Review.
-
Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy.Onco Targets Ther. 2016 May 27;9:3171-9. doi: 10.2147/OTT.S94151. eCollection 2016. Onco Targets Ther. 2016. PMID: 27313462 Free PMC article.
-
Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study.Radiat Oncol. 2015 Sep 17;10:189. doi: 10.1186/s13014-015-0495-4. Radiat Oncol. 2015. PMID: 26377326 Free PMC article.
-
Prognostic Factors Associated with 5-Year Overall Survival in Cervical Cancer Patients Treated with Radical Hysterectomy Followed by Adjuvant Concurrent Chemoradiation Therapy at a Tertiary Care Center in Eastern Europe.Diagnostics (Basel). 2021 Mar 22;11(3):570. doi: 10.3390/diagnostics11030570. Diagnostics (Basel). 2021. PMID: 33810019 Free PMC article.